ALLMedicine™ Dry Skin Center

Jul 22nd, 2021 - A 7-year-old girl born to consanguineous parents, had recurrent erythroderma since birth; she presented with intractable pruritus, scaling, dry skin and eczematous lesions, associated to fingers and toes onychogryphosis, along with refractory otit...

Jun 25th, 2021 - Learning to take control of one's health is an important part of the transition from adolescence to adulthood. This study aimed to explore young adults' perceptions of living with atopic dermatitis (AD) in relation to the concept of self-managemen...

Jun 25th, 2021 - Atopic dermatitis is a chronic inflammatory skin condition that affects patients of all ages. The disease is characterized by xerosis (dry skin) and intensely pruritic lesions distributed throughout the body. This article reviews diagnostic featur...

Jun 3rd, 2021 - Exposome factors that lead to stressed skin can be defined as any disturbance to homeostasis from environmental (meteorological factors, solar radiation, pollution or tobacco smoke) and/or internal exposure (unhealthy diet, hormonal variations, la...

Jun 3rd, 2021 - The pathophysiology of xerosis depends on extrinsic and intrinsic exposures. Residential hard water may constitute such an exposure. To estimate the prevalence of xerosis and to compare water hardness exposure in blood donors with and without xero...

Jul 19th, 2015 - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) such as gefitinib, erlotinib, and afatinib are standard-of-care for first-line treatment of EGFR-mutant advanced non-small cell lung cancer (NSCLC). These drugs have a prove...

Mar 13th, 2020 - Sun-damaged skin, caused by chronic exposure to ultraviolet (UV) light, is characterized by features such as wrinkling, uneven skin color, roughness and brown spots. An effective treatment for sun-damage that is commonly prescribed is topical reti...

Oct 21st, 2019 - The purpose of this study is to investigate experimental medication BMS-986251 taken by mouth in healthy patients and patients with average to very serious Psoriasis (a condition characterized by itchy, dry skin with a scaly rash).

Dec 27th, 2018 - This will be a single centre, evaluator blind, randomized, parallel group, stratified, two week study in healthy participants. The clinical study is designed to provide reassurance that the formulations developed for children and babies with mild ...

Oct 15th, 2018 - This is a research study to find out if a drug called, osimertinib, is safe and effective in treating advanced Non-Small Cell Lung Cancer (NSCLC) by targeting the treatment of epidermal growth factor receptor (EGFR) mutation exon 18 G719X, exon 20...

Oct 11th, 2018 - The goal of this study is to compare how the appearance of dry skin changes before and after the use of following moisturizers: white petrolatum, coconut oil, jojoba oil and almond oil). Up to 40 subjects from Banner-University Medical Center/Univ...

Jul 13th, 2021 - Dr Caroline Ward Dr Caroline Ward, GP and standing member of the National Institute for Health and Care Excellence (NICE) Managing Common Infections Advisory Committee, discusses NICE recommendations on the treatment of atopic eczema, focusing on ...

Summary Company Announcement Date: September 03, 2020 FDA Publish Date: September 03, 2020 Product Type: Drugs Reason for Announcement: Recall Reason Description Product may be sub potent Company Name: RLC Labs, Inc Brand Name: Brand Name(s) RLC L...

Summary Company Announcement Date: July 04, 2017 FDA Publish Date: February 08, 2018 Product Type: Medical Devices General Hospital & Personal Use Reason for Announcement: Recall Reason Description Device may crack or break if exposed to certain c...

May 15th, 2020 - The US Food and Drug Administration (FDA) has granted accelerated approval to pomalidomide (Pomalyst, Bristol-Myers Squibb) for the treatment of AIDS-related Kaposi sarcoma that is resistant to highly active antiretroviral therapy (HAART) or that ...

Apr 13th, 2020 - The Food and Drug Administration has approved selumetinib for the treatment of pediatric patients aged 2 years and older with type 1 neurofibromatosis (NF1) with symptomatic, inoperable plexiform neurofibromas. FDA approval was based on results fr...